Kollender Richard S 4
4 · RAPID MICRO BIOSYSTEMS, INC. · Filed Jul 20, 2021
Insider Transaction Report
Form 4
Kollender Richard S
Director
Transactions
- Conversion
Common Stock Warrant
2021-07-19+82,010→ 82,010 total(indirect: Held by Quaker Bioventures II, L.P.)Exercise: $0.05Exp: 2027-07-24→ Class A Common Stock (82,010 underlying) - Conversion
Series B1 Warrant
2021-07-19−64,516→ 0 total(indirect: Held by Quaker Bioventures II, L.P.)Exercise: $0.01Exp: 2028-01-17→ Series B1 Preferred Stock (64,516 underlying) - Conversion
Common Stock Warrant
2021-07-19+12,903→ 12,903 total(indirect: Held by Quaker Bioventures II, L.P.)Exercise: $0.05Exp: 2028-01-17→ Class A Common Stock (12,903 underlying) - Conversion
Series A1 Warrant
2021-07-19−410,051→ 0 total(indirect: Held by Quaker Bioventures II, L.P.)Exercise: $0.01Exp: 2027-07-24→ Series A1 Preferred Stock (410,051 underlying) - Conversion
Series A1 Preferred Stock
2021-07-19−4,623,796→ 0 total(indirect: Held by Quaker Bioventures II, L.P.)→ Class A Common Stock (924,759 underlying) - Conversion
Class A Common Stock
2021-07-19+1,315,084→ 1,373,193 total(indirect: Held by Quaker Bioventures II, L.P.) - Conversion
Series B1 Preferred Stock
2021-07-19−1,130,906→ 0 total(indirect: Held by Quaker Bioventures II, L.P.)→ Class A Common Stock (226,180 underlying) - Conversion
Series C1 Preferred Stock
2021-07-19−820,729→ 0 total(indirect: Held by Quaker Bioventures II, L.P.)→ Class A Common Stock (164,145 underlying)
Footnotes (4)
- [F1]The Series A1 Preferred Stock, the Series B1 Preferred Stock and the Series C1 Preferred Stock (collectively, the "Preferred Stock") are convertible at any time, at the holder's election and have no expiration date. Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering.
- [F2]These shares are held directly by Quaker Bioventures II, L.P. The Reporting Person is a managing director of Quaker Bioventures Capital II, L.P., the parent of Quaker Bioventures II, L.P. and may be deemed to beneficially hold the shares.
- [F3]The Issuer's Preferred Stock warrants automatically converted into warrants to purchase Common Stock immediately prior to the closing of the Issuer's initial public offering without payment or further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants.
- [F4]Immediately exercisable.